Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Lymphoma, Follicular × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Burkitt Lymphoma 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Rituximab 5 Lenalidomide 3 fludarabine 2 Cyclophosphamide 2 zanubrutinib 1 venetoclax 1 umbralisib 1 ublituximab 1 tisagenlecleucel 1 tazemetostat 1 tafasitamab 1 prednisolone phosphate 1 prednisolone acetate 1 pirtobrutinib 1 obinutuzumab 1 duvelisib 1 axicabtagene ciloleucel 1 Prednisolone 1 Methylprednisolone 1 Bendamustine Hydrochloride 1 Appointments and Schedules 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡